<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02028637</url>
  </required_header>
  <id_info>
    <org_study_id>43/2009</org_study_id>
    <nct_id>NCT02028637</nct_id>
  </id_info>
  <brief_title>Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.</brief_title>
  <official_title>Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Recently it has involved the role of TLR (toll-like receptors) in the
      pathogenesis of asthma. TLRs are a family of proteins responsible for the recognition of
      Pathogen-Associated Molecular Patters (PAMPs). The possible role that TLRs play in
      IgE-dependent asthma (not eosinophilic) and its recognition as a new endotype asthma, could
      open new therapeutic expectations.

      Objective: To analyze the expression of TLR 2 and 4 in monocytes/ macrophages and neutrophils
      in peripheral blood and induced sputum from asthmatic patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators studied patients with asthma. All patients underwent the same day an
      induced sputum, pulmonary function studies, fractional exhaled nitric oxide, blood total IgE
      and skin test by prick technique. Asthmatic patients were classified according to the
      criteria of the GINA 2012. The cellular composition was analyzed by flow cytometry.
      Expression of TLR2 and TLR4 were analyzed using monoclonal antibodies conjugated with
      fluorochromes appropriate.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic</measure>
    <time_frame>2 years</time_frame>
    <description>The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic (IgEnodep).This could suggest that in this type of asthma the defense mechanism of neutrophils could be altered by decreasing expression of these receptors on their cell surface. This mechanism would still be defined. Probably the respiratory infections play an important role.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>toll like receptor (TLRs)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TLRs are a family of proteins responsible for the recognition of Pathogen-Associated Molecular Patters</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TLRs</intervention_name>
    <description>Recently it has involved the role of TLR (toll-like receptors) in the pathogenesis of asthma.The possible role that TLRs play in the asthma and its recognition as a new endotype asthma, could open new therapeutic expectations.</description>
    <arm_group_label>toll like receptor (TLRs)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with persistent asthma (defined as per the Global INitiative for Asthma
             Management (GINA) criteria)

        Exclusion Criteria:

          -  If they had a respiratory tract infection or asthma exacerbation within 30 days prior
             to inclusion

          -  If they were receiving oral steroids or immunosuppressive treatments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Astrid Crespo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau). Universitat Autònoma de Barcelona, Department of Medicine.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003 Sep;22(3):470-7.</citation>
    <PMID>14516137</PMID>
  </reference>
  <reference>
    <citation>Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008 Sep 20;372(9643):1107-19. doi: 10.1016/S0140-6736(08)61452-X. Review.</citation>
    <PMID>18805339</PMID>
  </reference>
  <reference>
    <citation>Weiss ST. Eat dirt--the hygiene hypothesis and allergic diseases. N Engl J Med. 2002 Sep 19;347(12):930-1.</citation>
    <PMID>12239263</PMID>
  </reference>
  <reference>
    <citation>Gon Y. Toll-like receptors and airway inflammation. Allergol Int. 2008 Mar;57(1):33-7. doi: 10.2332/allergolint.R-07-157. Epub 2008 Mar 1. Review.</citation>
    <PMID>18209505</PMID>
  </reference>
  <reference>
    <citation>Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 2007 Mar;62(3):211-8. Epub 2006 Jul 14.</citation>
    <PMID>16844729</PMID>
  </reference>
  <reference>
    <citation>Crespo-Lessmann A, Juárez-Rubio C, Plaza-Moral V. [Role of toll-like receptors in respiratory diseases]. Arch Bronconeumol. 2010 Mar;46(3):135-42. doi: 10.1016/j.arbres.2009.07.011. Epub 2009 Sep 17. Review. Spanish.</citation>
    <PMID>19765883</PMID>
  </reference>
  <reference>
    <citation>Vidal S, Bellido-Casado J, Granel C, Crespo A, Plaza V, Juárez C. Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Immunobiology. 2012 Jul;217(7):692-7. doi: 10.1016/j.imbio.2011.11.008. Epub 2011 Dec 2.</citation>
    <PMID>22204819</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2014</study_first_submitted>
  <study_first_submitted_qc>January 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2014</study_first_posted>
  <last_update_submitted>January 4, 2014</last_update_submitted>
  <last_update_submitted_qc>January 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</investigator_affiliation>
    <investigator_full_name>Astrid Crespo</investigator_full_name>
    <investigator_title>Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau. Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau). Universitat Autònoma de Barcelona, Department of Medicine. Barcelona Respiratory Network (BRN). Barcelona, Spain.</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>toll like receptor</keyword>
  <keyword>innate immunity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

